Andrew Stoner is a Patent Agent and member of the firm’s Chemistry and Life Sciences Team.
He works closely with our chemical, biotechnology, and pharmaceutical clients on patent prosecution and IP portfolio management matters, with an emphasis on:
- CNS pharmaceuticals
- Therapeutic antibodies
- Liposomal pharmaceuticals
- Metabolic and GI pharmaceuticals
- Psychedelic-derived pharmaceuticals and their crystalline forms
- Enzymatic production of rare sugars.
Education:
- Georgetown University, Ph.D. Chemistry, 2023
- Salisbury University, B.S. Chemistry, 2018
Bar Admissions:
- Registered to practice before the U.S. Patent and Trademark Office
Prior Experience
- Registered to practice before the U.S. Patent and Trademark Office
Prior Experience
Andrew earned his Ph.D. in Chemistry from Georgetown University, where he studied the fundamental optical properties of 1D semiconductor and plasmonic nanomaterials, with a focus in Raman Spectroscopy.